Faculty of Pharmacy, Department of Pharmaceutical Technology, Erciyes University, 38039 Kayseri, Turkey.
Biomed Pharmacother. 2013 Jul;67(6):459-67. doi: 10.1016/j.biopha.2013.03.001. Epub 2013 Mar 23.
Nanoparticle and liposome formulations containing doxycycline or doxycycline and sodium taurocholate (NaTC) were developed in this study. The anticancer effects of doxycycline and penetration properties from those formulations through Caco-2 cell monolayers were investigated. Matrix metalloproteinases (MMPs) have been reported to play a role in the negative prognosis of many malignant tumors including glioblastoma multiforme (GBM). This study is presented to demonstrate that these developed nanoparticle and liposome formulations of doxycycline are capable of inhibiting MMP-2 release from cultured Caco-2 cells. In this study, Caco-2 cells were used as model cell cultures. A MTT test was performed to determine the effect of doxycycline on the viability of Caco-2 cells. Doxycycline nanoparticles were prepared using emulsion polymerization and doxycycline liposomes were prepared using the dry film hydration method. Transport studies of doxycycline through Caco-2 cells were investigated. MMP-2 was found to be inhibited more with doxycycline if NaTC is present in the formulation. NaTC was also found to be useful to increase penetration due to the inhibition of efflux by interacting with p-glycoproteins, in addition to the penetration enhancing effect as a result of opening tight junctions. These developed formulations were proposed to use for the treatment of tumors and GBM.
本研究制备了载多西环素或多西环素与牛磺胆酸钠(NaTC)的纳米粒和脂质体给药系统。考察了多西环素及其制剂在 Caco-2 细胞单层中的抗癌作用和渗透性能。基质金属蛋白酶(MMPs)已被报道在许多恶性肿瘤(包括多形性胶质母细胞瘤(GBM))的不良预后中发挥作用。本研究旨在证明这些开发的多西环素纳米粒和脂质体给药系统能够抑制 MMP-2 从培养的 Caco-2 细胞中释放。在本研究中,Caco-2 细胞被用作模型细胞培养物。通过 MTT 试验测定多西环素对 Caco-2 细胞活力的影响。采用乳液聚合法制备多西环素纳米粒,采用干膜水化法制备多西环素脂质体。考察了多西环素在 Caco-2 细胞中的转运研究。结果发现,如果制剂中存在 NaTC,则多西环素对 MMP-2 的抑制作用更强。此外,由于与 p-糖蛋白相互作用抑制外排,以及由于打开紧密连接而具有渗透增强作用,NaTC 还有助于增加渗透。这些开发的制剂拟用于治疗肿瘤和 GBM。